BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 27911758)

  • 1. Multimodal Imaging for DREADD-Expressing Neurons in Living Brain and Their Application to Implantation of iPSC-Derived Neural Progenitors.
    Ji B; Kaneko H; Minamimoto T; Inoue H; Takeuchi H; Kumata K; Zhang MR; Aoki I; Seki C; Ono M; Tokunaga M; Tsukamoto S; Tanabe K; Shin RM; Minamihisamatsu T; Kito S; Richmond BJ; Suhara T; Higuchi M
    J Neurosci; 2016 Nov; 36(45):11544-11558. PubMed ID: 27911758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemogenetics revealed: DREADD occupancy and activation via converted clozapine.
    Gomez JL; Bonaventura J; Lesniak W; Mathews WB; Sysa-Shah P; Rodriguez LA; Ellis RJ; Richie CT; Harvey BK; Dannals RF; Pomper MG; Bonci A; Michaelides M
    Science; 2017 Aug; 357(6350):503-507. PubMed ID: 28774929
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemogenetics-mediated acute inhibition of excitatory neuronal activity improves stroke outcome.
    Wang YC; Galeffi F; Wang W; Li X; Lu L; Sheng H; Hoffmann U; Turner DA; Yang W
    Exp Neurol; 2020 Apr; 326():113206. PubMed ID: 31962128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behavioral Effect of Chemogenetic Inhibition Is Directly Related to Receptor Transduction Levels in Rhesus Monkeys.
    Upright NA; Brookshire SW; Schnebelen W; Damatac CG; Hof PR; Browning PGF; Croxson PL; Rudebeck PH; Baxter MG
    J Neurosci; 2018 Sep; 38(37):7969-7975. PubMed ID: 30082415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of clozapine-N-oxide and compound 21 on sleep in laboratory mice.
    Traut J; Mengual JP; Meijer EJ; McKillop LE; Alfonsa H; Hoerder-Suabedissen A; Song SH; Fehér KD; Riemann D; Molnar Z; Akerman CJ; Vyazovskiy VV; Krone LB
    Elife; 2023 Mar; 12():. PubMed ID: 36892930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation by DREADD reveals the therapeutic effect of human iPSC-derived neuronal activity on functional recovery after spinal cord injury.
    Kitagawa T; Nagoshi N; Kamata Y; Kawai M; Ago K; Kajikawa K; Shibata R; Sato Y; Imaizumi K; Shindo T; Shinozaki M; Kohyama J; Shibata S; Matsumoto M; Nakamura M; Okano H
    Stem Cell Reports; 2022 Jan; 17(1):127-142. PubMed ID: 35021049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemogenetic Activation of Excitatory Neurons Alters Hippocampal Neurotransmission in a Dose-Dependent Manner.
    Pati S; Salvi SS; Kallianpur M; Vaidya B; Banerjee A; Maiti S; Clement JP; Vaidya VA
    eNeuro; 2019; 6(6):. PubMed ID: 31645362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-potency ligands for DREADD imaging and activation in rodents and monkeys.
    Bonaventura J; Eldridge MAG; Hu F; Gomez JL; Sanchez-Soto M; Abramyan AM; Lam S; Boehm MA; Ruiz C; Farrell MR; Moreno A; Galal Faress IM; Andersen N; Lin JY; Moaddel R; Morris PJ; Shi L; Sibley DR; Mahler SV; Nabavi S; Pomper MG; Bonci A; Horti AG; Richmond BJ; Michaelides M
    Nat Commun; 2019 Oct; 10(1):4627. PubMed ID: 31604917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemogenetic Regulation of CX3CR1-Expressing Microglia Using Gi-DREADD Exerts Sex-Dependent Anti-Allodynic Effects in Mouse Models of Neuropathic Pain.
    Saika F; Matsuzaki S; Kobayashi D; Ideguchi Y; Nakamura TY; Kishioka S; Kiguchi N
    Front Pharmacol; 2020; 11():925. PubMed ID: 32636748
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Hu F; Morris PJ; Bonaventura J; Fan H; Mathews WB; Holt DP; Lam S; Boehm M; Dannals RF; Pomper MG; Michaelides M; Horti AG
    Eur J Med Chem; 2021 Mar; 213():113047. PubMed ID: 33280897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does chronic systemic injection of the DREADD agonists clozapine-N-oxide or Compound 21 change behavior relevant to locomotion, exploration, anxiety, and depression in male non-DREADD-expressing mice?
    Tran FH; Spears SL; Ahn KJ; Eisch AJ; Yun S
    Neurosci Lett; 2020 Nov; 739():135432. PubMed ID: 33080350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo electrophysiological validation of DREADD-based modulation of pallidal neurons in the non-human primate.
    Deffains M; Nguyen TH; Orignac H; Biendon N; Dovero S; Bezard E; Boraud T
    Eur J Neurosci; 2021 Apr; 53(7):2192-2204. PubMed ID: 32306446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. G
    Marciante AB; Farmer GE; Cunningham JT
    J Neurophysiol; 2020 Aug; 124(2):591-609. PubMed ID: 32697679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice.
    Jendryka M; Palchaudhuri M; Ursu D; van der Veen B; Liss B; Kätzel D; Nissen W; Pekcec A
    Sci Rep; 2019 Mar; 9(1):4522. PubMed ID: 30872749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gi-DREADD Expression in Peripheral Nerves Produces Ligand-Dependent Analgesia, as well as Ligand-Independent Functional Changes in Sensory Neurons.
    Saloman JL; Scheff NN; Snyder LM; Ross SE; Davis BM; Gold MS
    J Neurosci; 2016 Oct; 36(42):10769-10781. PubMed ID: 27798132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemogenetic enhancement of functional recovery after a sciatic nerve injury.
    Jaiswal PB; English AW
    Eur J Neurosci; 2017 May; 45(10):1252-1257. PubMed ID: 28244163
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic neuronal stimulation increases human tau pathology and trans-synaptic spread of tau to distal brain regions in mice.
    Schultz MK; Gentzel R; Usenovic M; Gretzula C; Ware C; Parmentier-Batteur S; Schachter JB; Zariwala HA
    Neurobiol Dis; 2018 Oct; 118():161-176. PubMed ID: 30049665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral application of clozapine-N-oxide using the micropipette-guided drug administration (MDA) method in mouse DREADD systems.
    Schalbetter SM; Mueller FS; Scarborough J; Richetto J; Weber-Stadlbauer U; Meyer U; Notter T
    Lab Anim (NY); 2021 Mar; 50(3):69-75. PubMed ID: 33619409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic hM4Di-DREADD-Mediated Chemogenetic Inhibition of Forebrain Excitatory Neurons in Postnatal or Juvenile Life Does Not Alter Adult Mood-Related Behavior.
    Tiwari P; Kapri D; Pradhan A; Balakrishnan A; Chaudhari PR; Vaidya VA
    eNeuro; 2022; 9(1):. PubMed ID: 35115382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic AMP-producing chemogenetic activation of indirect pathway striatal projection neurons and the downstream effects on the globus pallidus and subthalamic nucleus in freely moving mice.
    Bouabid S; Zhou FM
    J Neurochem; 2018 Jun; 145(6):436-448. PubMed ID: 29500819
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.